EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials

Gabriel Grando Alves, Luisa Cunha, Rafael Henkes Machado, Vanessa Lins de Menezes iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15581 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Gabriel Grando Alves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Federal University of Santa Maria, Santa Maria, Brazil. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Hypoglycemic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim To provide updated efficacy and safety information for teplizumab in the treatment of Stage 3 type 1 diabetes mellitus (T1DM). Materials and Methods The PubMed, Embase and Cochrane databases were searched for randomized controlled trials (RCTs) comparing teplizumab to placebo for T1DM that reported any of the following outcomes: (1) C‐peptide area under the curve (AUC); (2) glycated haemoglobin (HbA1c) levels; (3) insulin requirements; and (4) adverse events. Heterogeneity was examined with I 2 statistics. p values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedDiabetes Mellitus, Type 1Glycated HemoglobinHypoglycemic AgentsAdultFemaleHumansMaleC-PeptideHypoglycemiaInsulinRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

C‐peptideT1DManti‐CD3 monoclonal antibodymeta‐analysissystematic reviewteplizumabtype 1 diabetes mellitus

Substanzen

Antibodies, Monoclonal, HumanizedC-PeptideGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinteplizumab

Autor:innen und Institutionen

  • Department of Medicine, Federal University of Santa Maria, Santa Maria, Brazil.
  • Department of Medicine, Lusíada University Center, São Paulo, Brazil.
  • Department of Medicine, University of Southern Santa Catarina, Palhoça, Brazil.
  • Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

ORCID-Profile: Vanessa Lins de Menezes

Zitieren

APA

Grando Alves, G., Cunha, L., Henkes Machado, R., & Lins de Menezes, V. (2024). Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15581

Vancouver

Grando Alves G, Cunha L, Henkes Machado R, Lins de Menezes V. Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15581

BibTeX
@article{GrandoAlves2024,
  author = {Grando Alves, Gabriel and Cunha, Luisa and Henkes Machado, Rafael and Lins de Menezes, Vanessa},
  title = {Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15581}
}
Kostenlos starten →